Is pentraxin 3 involved in obesity-induced decrease in arterial distensibility?

Journal of Atherosclerosis and Thrombosis

Volumn 17, Issue 3, 2010, Pages 278-284

  Miyaki, Asako ^a   Maeda, Seiji ^a   Yoshizawa, Mutsuko ^a   Misono, Maiko ^a   Sasai, Hiroyuki ^a   Shimojo, Nobutake ^a   Tanaka, Kiyoji ^a   Ajisaka, Ryuichi ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Obesity; PTX3; Vascular inflammation

Indexed keywords

PENTRAXIN 3;

ADULT; ARTERIAL PRESSURE; ARTERY COMPLIANCE; ARTERY DISEASE; ARTICLE; B SCAN; BODY MASS; CAROTID ARTERY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; HUMAN; MALE; OBESITY; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; TONOMETRY;

EID: 77951162180     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.2741     Document Type: Article

References (37)

1. Hubert HB, Manning F: Obesity is an independent risk factor for cardiovascular disease: A 26-year follow-up of participants in the Framingham Heart Study. Circulation, 1983; 67: 968-977
2. Wang TJ: Obesity and the risk of new-onset arterial fibrillation. JAMA, 2004; 292: 2471-2477
3. Hodes RJ, Lakatta EG, McNeil CT: Another modifiable risk factor for cardiovascular disease? Some evidence points to arterial stiffness. J Am Geriatr Soc, 1995; 43: 581-582
4. Safar ME, London GM: Therapeutic studies and arterial stiffness in hypertension: Recommendations of the Euro-pean Society of Hypertension. The Clinical Committee of Arterial Structure and Function. J Hypertens, 2000; 18: 1527-1535
5. Danias PG, Tritos NA, Stuber M, Botnar RM, Kissinger KV, Manning WJ: Comparison of aortic elasticity deter-mined by cardiovascular magnetic resonance imaging in obese versus lean adults. Am J Cardiol, 2003; 91: 195-199
6. Wildman RP, Mackey RH, Bostom A, Thompson T, Sut-ton-Tyrrell K: Measures of obesity are associated with vas-cular stiffness in young and older adults. Hypertension, 2003; 42: 468-473
7. Clement K, Langin D: Regulation of inflammation-related genes in human adipose tissue. J Intern Med, 2007; 262: 422-430
8. Ridker PM, Hennekens CH, Buring JE, Rifai N: C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med, 2000; 342: 836-843
9. Ridker PM, Rifai N, Stampfer MJ, Hennekens CH: Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation, 2000; 101: 1767-1772
10. Ridker PM, Rifai N, Pfeffer M, Sacks F, Lepage S, Braun-wald E: Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocar-dial infarction. Circulation, 2000; 101: 2149-2153
11. Martinovic I, Abegunewardene N, Seul M, Vosseler M, Horstick G, Buerke M, Darius H, Lindemann S: Ele-vated monocyte chemoattractant protein-1 serum levels in patients at risk for coronary artery disease. Circ J, 2005; 69: 1484-1489
12. Hwang SJ, Ballantyne CM, Sharrett AR, Smith LC, Davis CE, Gotto AM Jr, Boerwinkle E: Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: The atherosclerosis risk in communities (ARIC) study. Circulation, 1997; 96: 4219-4225
13. Suzuki S, Takeishi Y, Niizeki T, Koyama Y, Kitahara T, Sasaki T, Sagara M, Kubota I: Pentraxin 3, a new marker for vascular inflammation, predicts adverse clinical out-comes in patients with heart failure. Am Heart J, 2008; 155: 75-81
14. Presta M, Camozzi M, Salvatori G, Rusnati M: Role of soluble pattern recognition receptor PTX3 in vascular biol-ogy. J Cell Mol Med, 2007; 11: 723-738
15. Ortega-Hernandez O, Bassi N, Shoenfield Y, Anaya JM: The long pentraxin 3 and its role in autoimmunity. Semin Arthritis Rheum, 2008; doi: 10.1016/ j.semarthrit. 2008. 03.006
16. Rolph MS, Zimmer S, Bottazzi B, Garlanda C, Man-tovani A, Hansson GK: Production of the long pentraxin PTX3 in advanced atherosclerotic plaques. Arterioscler Thromb Vasc Biol, 2002; 22: e10-14
17. Muller B, Peri G, Doni A, Torri V, Landmann R, Bottazzi B, Mantovani A: Circulating levels of the long pentraxin PTX3 correlate with severity of infection in critically ill patients. Crit Care Med, 2001; 29: 1404-1407
18. White WB, Elliott WJ, Johnson MF, Black HR: Chronotherapeutic delivery of verapamil in obese versus non-obese patients with essential hypertension. J Hum Hyper-tens, 2001; 15: 135-141
19. Van Bortel LM, Duprez D, Starmans-Kool MJ, Safer ME, Giannattasio C, Cockcroft J, Kaiser DR, Thuillez C: Clinical applications of arterial stiffness, task force 3: Recommendations for user producers. Am J Hypertens, 2002; 15: 445-452
20. Hirai T, Sasayama S, Kawasaki T, Yagi S: Stiffness of sys-temic arteries in patients with myocardial infarction: A noninvasive method to predict severity of coronary ath-erosclerosis. Circulation, 1989; 80: 78-86
21. Trayhum P, Wood IS: Adipokine: Inflammation and the pleiotropic role of white adipose tissue. Br J Nutr, 2004; 92: 347-355
22. Kern PA, Ranganathan S, Li C, Wood L, Ranganathan G: Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol, 2001; 280: E745-751
23. Matsuda M, Shimomura I, Sata M, Arita Y, Maeda N, Kumada M, Okamoto Y, Nakaretani H, Nishizawa H, Kishida K, Komuro R, Ouchi N, Kihara S, Nagai R, Funahashi T, Matsuzawa Y: Role of adiponectin in pre-venting vascular stenosis. The missing link of adipovascu-lar axis. J Biol Chem, 2002; 277: 37487-37491
24. Cybulsky MI, Iiyama K, Li H, Zhu S, Chen M, Iiyama M, Davis V, Gutierrez-Ramos J, Connelly PW, Milstone DS: A major role for VCAM-1, but not ICAM-1, in early ath-erosclerosis. J Clin Invest, 2001; 107: 1255-1262
25. Rifai N, Tracy RP, Ridker PM: Clinical efficacy of an automated high-sensitivity C-reactive protein assey. Clin Chem, 1999; 45: 2136-2142
26. Koening W, Sund M, Frohlich M, Fischer HG, Lowel H, Dorning A, Hutchinson WL, Pepys MB: C-reactive pro-tein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men. Results from the MONICA (Monitoring Trends and Detarminants Cardiovascular Disease) Augs-burg Cohort Study, 1984 to 1992. Circulation, 1999; 99: 237-242
27. Ross R: The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature, 1993; 362: 801-809
28. Ross R, Harker L: Hyperlipidemia and athelosclerosis. Science, 1976; 193: 1094-1100
29. Ohsuzu F: The roles of cytokines, inflammation and immu-nity in vascular diseases. J Atheroscler Thromb, 2004; 11: 313-321
30. Mahmud A, Feely J: Arterial stiffness is related to systemic inflammation in essential hypertension. Hypertension, 2005; 46: 1118-1122
31. Maki-Pataja KM, Hall FC, Booth AD, Wallace SM, Bear-croft PW, Harish S, Furlong A, McEniery CM, Brown J, Wilkinson IB: Rheumatoid arthritis is associated with increased aortic pulse-wave velocity, which is reduced by anti-tumor necrosis factor-alpha therapy. Circulation, 2006; 114: 1185-1192
32. Gaillard V, Casellas D, Seguin-Devalux C, Schohn H, Dauca M, Atkinson J, Lartaud I: Pioglitazone improves aortic wall elasticity in a rat model of elastocalcinotic arte-riosclerosis. Hypertension, 2005; 46: 372-379
33. Savchenko AS, Imamura M, Ohashi R, Jiang S, Kawasaki T, Hasegawa G, Emura I, Iwanari H, Sagara M, Tanaka M, Hamakubo T, Kodama T, Naito M: Expression of pentraxin 3 (PTX3) in human atherosclerotic lesions. J Pathol, 2008; doi: 10.1002/ path.2314
34. Klouche M, Peri G, Knabbe C, Eckstein HH, Schimid FX, Schimitz G, Mantovani A: Modified atherogenic lipoproteins induce expression of pentraxin-3 by human vascular smooth muscle cells. Atherosclerosis, 2004; 175: 221-228
35. Napoleone E, Di Santo A, Bastone A, Peri G, Mantovani A, de Gaetano G, Donati MB, Lorenzet R: Long pen-traxin PTX3 upregulates tissue factor expression in human endothelial cells. A novel link between vascular inflammation and clotting activation. Arterioscler Thromb Vasc Biol, 2002; 22: 782-787
36. Inoue K, Sugiyama A, Reid PC, Ito Y, Miyauchi K, Mukai S, Sagara M, Miyamaoto M, Satoh H, Kohno I, Kurata T, Ota H, Mantovani A, Hamakubo T, Daida H, Kodama T: Establishment of a high sensitivity plasma assay for human pentraxin3 as a marker for unstable angina pecto-ris. Arterioscler Thromb Vasc Biol, 2007: 27; 161-167
37. Peri G, Introna M, Corradi D, Iacuitti G, Signorini S, Avanzini F, Pizzetti F, Maggioni AP, Moccetti T, Metra M, Cas LD, Ghezzi P, Sipe JD, Re G, Olivetti G, Mantovani A, Latini R: PTX3, a prototypical long pentraxin, is an early indicator of acute myocardial infarction in humans. Circulation, 2000; 102: 636-641